Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
10.64
-0.22 (-2.03%)
Apr 13, 2026, 10:47 AM EDT - Market open
Perrigo Company Revenue
In the year 2025, Perrigo Company had annual revenue of $4.25B, down -2.75%. Perrigo Company had revenue of $1.11B in the quarter ending December 31, 2025, a decrease of -2.52%.
Revenue (ttm)
$4.25B
Revenue Growth
-2.75%
P/S Ratio
0.34
Revenue / Employee
$525,074
Employees
8,100
Market Cap
1.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.25B | -120.30M | -2.75% |
| Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
| Dec 31, 2019 | 3.87B | -861.80M | -18.21% |
| Dec 31, 2018 | 4.73B | -214.50M | -4.34% |
| Dec 31, 2017 | 4.95B | -334.40M | -6.33% |
| Dec 31, 2016 | 5.28B | 337.60M | 6.83% |
| Dec 31, 2015 | 4.94B | - | - |
| Sep 26, 2015 | 4.94B | 715.90M | 16.94% |
| Jun 27, 2015 | 4.23B | 313.00M | 8.00% |
| Jun 28, 2014 | 3.91B | 374.30M | 10.57% |
| Jun 29, 2013 | 3.54B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.27B |
| Phibro Animal Health | 1.46B |
| Evotec SE | 925.65M |
| ANI Pharmaceuticals | 883.37M |
| BioCryst Pharmaceuticals | 874.84M |
| Collegium Pharmaceutical | 780.57M |
| Pacira BioSciences | 726.41M |
| Alvotech | 588.90M |
PRGO News
- 4 weeks ago - 8 Stocks to Buy as Merger-Mania Takes Over - Benzinga
- 5 weeks ago - 5 Small Caps With Yields Up To 11% That Punch Like Heavyweights - Forbes
- 5 weeks ago - Perrigo to Present at the UBS Global Consumer and Retail Conference - PRNewsWire
- 5 weeks ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga
- 6 weeks ago - Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations - PRNewsWire
- 7 weeks ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 2 months ago - Perrigo to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 - PRNewsWire
- 3 months ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of January 16, 2026 in Perrigo Company plc Lawsuit – PRGO - GlobeNewsWire